FDA Withdraws Approval of Allergan's LO MINASTRIN FE Drug Application

Summary

The US Food and Drug Administration (FDA) has withdrawn approval of a new drug application for LO MINASTRIN FE, a birth control medication developed by Allergan Pharmaceuticals International, LTD, following a notification from the company that the product is no longer being marketed.